Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Anthrax toxin

  • Open Access
    Proteases as Activators for Cytotoxic Prodrugs in Antitumor Therapy
    ULRICH H. WEIDLE, GEORG TIEFENTHALER and GUY GEORGES
    Cancer Genomics & Proteomics March 2014, 11 (2) 67-79;
  • Open Access
    Prospects of Bacterial and Plant Protein-based Immunotoxins for Treatment of Cancer
    ULRICH H. WEIDLE, GEORG TIEFENTHALER, CHRISTIAN SCHILLER, ELISABETH H. WEISS, GUY GEORGES and ULRICH BRINKMANN
    Cancer Genomics & Proteomics January 2014, 11 (1) 25-38;
Cancer & Genome Proteomics

© 2026 Cancer Genomics & Proteomics

Powered by HighWire